DNA X, Inc. SONM
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -64.68% | 241.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -64.68% | 121.12% | |||
| Operating Income | 64.68% | -495.41% | |||
| Income Before Tax | 68.48% | -733.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 68.48% | -930.97% | |||
| Earnings from Discontinued Operations | -100.09% | 220.71% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -119.67% | 171.34% | |||
| EBIT | 64.68% | -495.41% | |||
| EBITDA | 52.38% | -205.47% | |||
| EPS Basic | -118.42% | 153.42% | |||
| Normalized Basic EPS | 65.93% | -238.10% | |||
| EPS Diluted | -118.42% | 153.46% | |||
| Normalized Diluted EPS | 65.93% | -238.10% | |||
| Average Basic Shares Outstanding | 6.78% | 75.05% | |||
| Average Diluted Shares Outstanding | 6.78% | 75.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||